BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schätzl T, Kaiser L, Deigner HP. Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update. Orphanet J Rare Dis 2021;16:129. [PMID: 33712050 DOI: 10.1186/s13023-021-01760-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Marwaha S, Knowles JW, Ashley EA. A guide for the diagnosis of rare and undiagnosed disease: beyond the exome. Genome Med 2022;14. [DOI: 10.1186/s13073-022-01026-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
2 Kostyuk SV, Proskurnina EV, Ershova ES, Kameneva LV, Malinovskaya EM, Savinova EA, Sergeeva VA, Umriukhin PE, Dolgikh OA, Khakina EA, Kraevaya OA, Troshin PA, Kutsev SI, Veiko NN. The Phosphonate Derivative of C60 Fullerene Induces Differentiation towards the Myogenic Lineage in Human Adipose-Derived Mesenchymal Stem Cells. Int J Mol Sci 2021;22:9284. [PMID: 34502190 DOI: 10.3390/ijms22179284] [Reference Citation Analysis]
3 Wang Z, Qiu L, Lin M, Chen L, Zheng F, Lin L, Lin F, Ye Z, Lin X, He J, Wang L, Lin X, He Q, Chen W, Lin Y, Fu Y, Wang N. Prevalence and disease progression of genetically-confirmed facioscapulohumeral muscular dystrophy type 1 (FSHD1) in China between 2001 and 2020: a nationwide population-based study. Lancet Reg Health West Pac 2022;18:100323. [PMID: 35024656 DOI: 10.1016/j.lanwpc.2021.100323] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Mocciaro E, Runfola V, Ghezzi P, Pannese M, Gabellini D. DUX4 Role in Normal Physiology and in FSHD Muscular Dystrophy. Cells 2021;10:3322. [PMID: 34943834 DOI: 10.3390/cells10123322] [Reference Citation Analysis]
5 Vecellio Reane D, Cerqua C, Sacconi S, Salviati L, Trevisson E, Raffaello A. The Splicing of the Mitochondrial Calcium Uniporter Genuine Activator MICU1 Is Driven by RBFOX2 Splicing Factor during Myogenic Differentiation. Int J Mol Sci 2022;23:2517. [PMID: 35269658 DOI: 10.3390/ijms23052517] [Reference Citation Analysis]
6 Banerji CRS, Zammit PS. Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7. EMBO Mol Med 2021;13:e13695. [PMID: 34151531 DOI: 10.15252/emmm.202013695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]